Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Browsing Tag

Innovation

166 posts
NNovartis
Novartis advances multiple sclerosis innovation with late-breaking remibrutinib and broad portfolio data at MSToronto2026
Read More

Novartis receives European Commission approval for

  • 2026-10-21
Cosentyx® (secukinumab) becomes first and only IL-17A inhibitor approved in Europe for adults with PMR,1 a common inflammatory…
GGlencore
Global Mining Review
Read More

The mill that changed fine grinding: Glencore Technology’s IsaMill™ turns 30

  • 2026-10-13
Originally developed through a partnership between Mount Isa Mines and NETZSCH to solve a complex metallurgical challenge, the…
GGeneva
WIPO
Read More

Postcards from WIPO: What’s Ahead for IP in Geneva This Fall

  • 2026-10-08
“The United States remains home to 20 of the world’s top 100 science and technology clusters.” I am…
NNovartis
Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)
Read More

Novartis Rhapsido® (remibrutinib) receives FDA approval as

  • 2026-10-08
In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12…
BBern
Members in the Parliamentary Group for startups and Entrepreneurship
Read More

A stronger voice for Swiss startups in Bern

  • 2026-10-06
The Parliamentary Group for Startups and Entrepreneurship met again during Parliament’s autumn session, running from 14 September to…
AABB
Vale and ABB form strategic alliance to accelerate digital transformation in iron ore operations in Brazil
Read More

Vale and ABB form strategic alliance to accelerate digital transformation in iron ore operations in Brazil

  • 2026-09-27
Carlos Medeiros, Vale’s Vice President of Operations, and Joachim Braun, President of ABB’s Process Industries Division, sign the agreement for…
NNovartis
Fortune includes Novartis in 2026 Change The World List for malaria program
Read More

Fortune includes Novartis in 2026 Change The World List for malaria program

  • 2026-09-23
Novartis has been named to Fortune’s Change the World 2026 list in recognition of our malaria program, one…
RRoche
Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
Read More

Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases

  • 2026-09-23
The center will be a hub for Roche and Genentech, bringing together expertise in Cardiovascular, Renal and Metabolism,…
RRoche
Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
Read More

Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases

  • 2026-09-22
F. Hoffmann-La Roche Ltd The center will be a hub for Roche and Genentech, bringing together expertise in…
RRoche
Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
Read More

Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases

  • 2026-09-21
F. Hoffmann-La Roche Ltd The center will be a hub for Roche and Genentech, bringing together expertise in…
RRoche
Roche opens Innovation Centre in US to drive advancements in Cardiovascular, Renal and Metabolic diseases
Read More

Roche opens Innovation Centre in US to drive advancements in Cardiovascular, Renal and Metabolic diseases

  • 2026-09-21
Roche opens Innovation Centre in US to drive advancements in Cardiovascular, Renal and Metabolic diseases September 21, 2026…
RRoche
Roche opens Innovation Centre in US to drive advancements in Cardiovascular, Renal and Metabolic diseases
Read More

Roche opens Innovation Centre in US to drive advancements in Cardiovascular, Renal and Metabolic diseases

  • 2026-09-21
Roche opens Innovation Centre in US to drive advancements in Cardiovascular, Renal and Metabolic diseases September 21, 2026…
Switzerland
www.europesays.com